Home PageHome Page

NMP 22

Test Code
Supplies available from PAML Supply Department.
Supply Item NumberTube from ARUP
Specimen TypeFrozen urine
Preferred Volume5 mL
Patient PrepTesting with the Matritech NMP22® should not be performed on patients who have had a total cystectomy or an invasive procedure, such as cystoscopy or catheterization of the urethra, within five days.
Collection ProcedureCollect a single void of urine between midnight and noon. Immediately following collection, add urine to NMP22 urine stabilizer vial and freeze.
Specimen ProcessingStabilized urine should be blue-green.
Store and TransportFrozen
StabilityRoom Temp 2 days  Refrigerated 3 days  Frozen (-20 °C) 1 month  
Unacceptable ConditionNonstabilized urine
CPT Codes86316
Billing CodeNMP22
Test ScheduleMon, Thu
Turnaround Time2-8 days
Test IncludesNMP22, U/mL
Reference Ranges
NMP22     0.0-10.0 U/mL
 The NMP22 assay is intended as an aid
 in the management of patients with
 transitional cell carcinoma of the 
 urinary tract (TCC/UT). It is used
 after surgical treatment to identify
 patients with residual or rapidly
 recurring TCC/UT.
NotesValues obtained with different assay methods should not be used interchangeably. ARUP uses the Matritech NMP22 Test Kit, which is an EIA method.
Urine stabilization kit is available from the PAML Supply Department.

Interface Codes
typeorder codetest descriptionresult coderesult descriptionunitsdecimal placesloinc code
o86316.Z3NMP 22